Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

RTTNews | 509日前
Stocktwits
Walgreens Boots Alliance Slashes FY23 Adj. EPS Outlook; Stock Down 7% - Update

(RTTNews) - While reporting financial results for the third quarter on Tuesday, Walgreens Boots Alliance, Inc. (WBA) slashed its adjusted earnings guidance for the full-year 2023 to a range of $4.00 to $4.05 per share from the prior forecast range of $4.45 to $4.65 per share, reflecting challenging consumer and macroeconomic conditions, and lower COVID-19 vaccine and testing volumes.

On average, 16 analysts polled by Thomson Reuters expect the company to report earnings of $4.46 per share for the year. Analysts' estimates typically exclude special items.

The company said the fourth quarter is expected to be negatively impacted by a higher effective tax rate, shifting U.S. consumer spending with heightened macro pressures, and the impact of a weaker respiratory season for both U.S. Retail Pharmacy and U.S. Healthcare.

For the fiscal year 2024, Walgreens Boots Alliance is providing preliminary expectations for low- to mid-single digit adjusted operating income growth, with the U.S. Healthcare and U.S. Retail Pharmacy performance more than offsetting headwinds from lower sale and leaseback program benefits, lower COVID-19 contribution, and the sale of holdings in AmerisourceBergen.

The company also raised its Transformational Cost Management Program target to $4.1 billion from $3.5 billion in cumulative savings by fiscal 2024. It is also expecting cost savings of $800 million in fiscal 2024.

The Company said its capital allocation continues to focus on core investments, debt paydown, and dividend payments.

タグ: WBA
Stocktwits
read more
Walgreens To Close 1,200 US Stores

Walgreens To Close 1,200 US Stores

Walgreens announced its plan to close around 1,200 U.S stores over the next three years, including around 500 closures in fiscal 2025, as the drug store chain is facing a challenging U.S. retail environment amid increasing competition. The move, which was announced while reporting a significantly wider net loss in its fourth quarter, is expected to be immediately accretive to adjusted earnings...
RTTNews | 32日前
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | 258日前
FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

FDA Warns CVS Health, Walgreens Against Unapproved Eye Products

The U.S. Food and Drug Administration has warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. The agency has issued warning letters to these companies as part of its ongoing effort to protect Americans from potentially harmful ophthalmic products.
RTTNews | 431日前
Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

Walgreens, Pearl Health Partner To Boost Value-Based Care Delivery

Walgreens, a division of Walgreens Boots Alliance, Inc. (WBA), has inked a partnership with Pearl Health to boost and expand value-based care to patients in Medicare in partnership with community-based primary care physicians. The partnership with Pearl Health will enable Walgreens to transition quickly and effectively to value-based care and improve outcomes in the communities they serve.
RTTNews | 432日前
Walgreens, CVS Reportedly Plan To Offer Abortion Pills

Walgreens, CVS Reportedly Plan To Offer Abortion Pills

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. are planning to offer abortion pills after the U.S. Food and Drug Administration decided to allow retail pharmacies to sell the product in the United States, reports said. On Tuesday, the agency announced a regulatory change allowing mifepristone, which is used in first-trimester abortions, to be dispensed by retail pharmacies.
RTTNews | 682日前
ツール
政経カレンダー
Market Hours
Interest Rates
Holidays Calendar
外国為替市場
外国為替ボラティリティ
外国為替相関
外国為替ニュース
forex analysis
COTデータ
流動性
外国為替計算機
外国為替ヒートマップ
Indicators Heatmap
コミュニティ
コミュニティ
システム
最も人気のあるシステム
戦略
コンテスト
外国為替チャート
外国為替センチメント
アウトルックインジケーター
レビュー
ブローカー
Prop Trading Firms
VPSサービス
シグナルプロバイダー
EAプログラミングサービス
Affiliate Programs
PAMMブローカーサービス
リベートプログラムサービス
取引プラットフォーム
エキスパートアドバイザー
仮想通貨交換所
Trading Courses
ブローカー
外国為替スプレッド
外国為替ブローカーの見積もり
外国為替ブローカーのスワップ
外国為替ブローカーボリューム
外国為替ブローカーのプロモーション Broker News
プラットフォーム
ウィジェット
機能
API
RSS
Stock Portfolio
Affiliate Software
高度なチャート
サポート
質問
ヘルプ
お問い合わせ
バグを報告！
私たちについて
ブログ
© 2024 Myfxbook Ltd。全著作権所有。
ハイリスクの警告：外国為替取引にはハイリスクが伴っているので、全ての人に適しているとは限りません。 レバレッジは、追加のリスクと損失のエクスポージャーを生み出します。 外国為替取引を決定する前に、あなたの投資目的、経験レベル、リスク許容度を慎重に検討してください。 初期投資の一部及びその全ての失う可能性があるので、必要最低限以上のお金は投資しないでください。 外国為替取引に関連するリスクについては、自分自身で学んで質問がある場合は独立した財務や税務顧問に質問してください。 データと情報は全て'そのままの形'で提供されます。それらは情報提供のみを目的としており、取引目的やアドバイスを目的としたものではありません。 過去の実績は、将来の結果を示すものではありません。